Spontaneous network activity (SNA) has been described in most developing circuits, including the spinal cord, retina, and hippocampus. Despite the widespread nature of this developmental phenomenon, its role in network maturation is poorly understood. We reduced SNA in the intact embryo and found compensatory increases in synaptic strength of spinal motoneuron inputs. AMPAergic miniature postsynaptic current (mPSC) amplitude and frequency increased following the reduction of activity. Interestingly, excitatory GABAergic mPSCs also increase in amplitude through a process of synaptic scaling. Finally, the normal modulation of GABAergic mPSC amplitude was accelerated. Together, these compensatory responses appear to increase the excitability of the cord and could act to maintain appropriate SNA levels, thus demonstrating a distinct functional role for synaptic homeostasis. Because spontaneous network activity can regulate AMPAergic and GABAergic synaptic strength during development, SNA is likely to play an important role in a coordinated maturation of excitatory and inhibitory synaptic strength.
Introduction
Virtually all developing circuits that have been examined express a network-driven periodic bursting activity shortly after synaptic connections form (Ben-Ari, 2001; Feller, 1999; Fortin et al., 1995; Gummer and Mark, 1994; Ho and Waite, 1999; Itaya et al., 1995; Lippe, 1995; O'Donovan, 1999; Wong, 1999) . This activity, hereafter referred to as ''spontaneous network activity'' (SNA), exists as episodic bursts of spiking activity that last for seconds and are followed by longer-lasting quiescent periods. These bursts or episodes are a consequence of the hyperexcitable nature of a recurrently connected synaptic circuit, in which chloride-mediated neurotransmission is excitatory in early development (Ben-Ari et al., 1989; Ben-Ari, 2002; Rivera et al., 1999) . During spontaneous network activity, the majority of cells fire action potentials and experience increases in cytoplasmic calcium, important in several aspects of development (Katz and Shatz, 1996; Spitzer, 2002; Zhang and Poo, 2001) . Despite its widespread nature, we have a poor understanding of how SNA influences the maturation of the networks that generate it.
Embryonic limb movements are produced by spontaneous network activity generated in the developing spinal cord (Bekoff et al., 1975; Hamburger, 1977; O'Donovan et al., 1998) . SNA is known to be important in motoneuron axonal pathfinding (Hanson and Landmesser, 2004 ) and for proper muscle and joint development (Hall and Herring, 1990; Jarvis et al., 1996; Persson, 1983; Roufa and Martonosi, 1981; Ruano-Gil et al., 1978; Toutant et al., 1979) . Embryonic limb movements have been studied in detail for over 100 years (Preyer, 1885; Preyer, 1937) . However, little progress has been made in understanding certain aspects of SNA, which drive these movements. For instance, what function does SNA play in the maturation of the circuits in which it is expressed? Further, how are appropriate levels of SNA maintained in order for circuit and limb development to proceed properly? Regulation of SNA must occur during a dynamic period when many developmental phenomena can alter the circuit's excitability (e.g., changing number of synaptic inputs, increases in cell size).
One possibility is that SNA is important in its own regulation. Activity patterns or levels of activity can be homeostatically regulated by cells or networks. Cultured isolated cells from the lobster stomatogastric ganglion, in the absence of synaptic inputs, are capable of homeostatically recovering normal intact bursting patterns by changing intrinsic membrane properties (Marder et al., 1996; Turrigiano et al., 1994 Turrigiano et al., , 1995 . In other studies, homeostatic recovery of the level of spiking activity was demonstrated, but was associated with compensatory changes in AMPAergic synaptic strength (Turrigiano et al., 1998; Burrone et al., 2002) . Several studies have blocked or significantly reduced spiking activity, and although recovery of normal activity levels was not shown, compensatory changes in synaptic strength were demonstrated that acted in a direction to recover normal levels of activity (Burrone and Murthy, 2003; Burrone et al., 2002; Davis and Bezprozvanny, 2001; Desai et al., 2002; Kilman et al., 2002; O'Brien et al., 1998; Paradis et al., 2001; Perez-Otano and Ehlers, 2005; Thiagarajan et al., 2002; Turrigiano et al., 1998; Turrigiano and Nelson, 2004; Wang et al., 2005) . In these studies, several different synaptic modifications were observed, both pre-and postsynaptically. Synaptic scaling is one particular class of compensatory synaptic modification that has received considerable attention recently; following activity level perturbations, the entire distribution of mPSC amplitudes are increased or decreased by a multiplicative factor, in a direction that would likely act to recover normal activity levels. (Desai et al., 2002; Kilman et al., 2002; Turrigiano et al., 1998; Turrigiano and Nelson, 2004) . Therefore, cells or networks can alter several properties that are likely to compensate for activity perturbations.
In this report, we have tested the hypothesis that reducing spontaneous network activity for 2 days in the living chick embryo would result in compensatory changes in synaptic strength, by synaptic scaling and/ or other compensatory forms of synaptic modulation. SNA was reduced by injecting the sodium channel blocker lidocaine in ovo. We then measured the synaptic strength of AMPAergic and GABAergic inputs in identified spinal motoneurons. Consistent with our hypothesis, we found that AMPAergic mPSC amplitude and frequency increased in a compensatory manner following the 2 day reduction of SNA. Interestingly, we also observed an increase in GABAergic mPSC amplitude by synaptic scaling. Although, this is in an opposite direction to that described in culture (Kilman et al., 2002) , it was compensatory because GABA, which will become inhibitory in the adult, is depolarizing and excitatory at this embryonic stage. Additionally, we observed a form of synaptic compensation in which the SNA-induced depression of GABAergic mPSC amplitude recovered at a faster rate in the activity-reduced preparations. Therefore, a reduction in spontaneous network activity produced multiple compensatory responses in excitatory GABAergic and AMPAergic synaptic strength. The findings broaden our understanding of the roles that activity-dependent synaptic compensation (synaptic homeostasis) may play in developing circuits-in this case, by maintaining SNA at appropriate levels. Further, SNA could coordinately regulate the development of synaptic strength for both excitatory and what will become inhibitory inputs as they face common challenges to efficacy during development. As a result, SNA is likely to play a critical role in the early maturation of synaptic strength in the motor system and may be important in the development of a balance between excitatory and inhibitory systems.
Results

Properties of Spontaneous Postsynaptic Currents
We reduced spontaneous network activity in ovo in order to test the hypothesis that this activity regulates the synaptic strength of inputs to embryonic motoneurons. Because we have assessed synaptic strength by measuring the amplitude and the frequency of spontaneous postsynaptic currents (sPSCs), it was initially necessary to consider certain characteristics of the sPSCs. First, synaptic strength is typically measured from action potential-independent miniature postsynaptic currents, thought to represent quantal release. Therefore, we wanted to establish that the sPSCs were in fact mPSCs. Second, we wanted to establish which neurotransmitters contributed to this population of inputs so that we could follow lidocaine-induced changes in each population separately. Third, because we found only two classes of mPSCs, we wanted to determine whether it would be possible to isolate these distinct populations of mPSCs by their kinetics. This is important because it would allow the simultaneous acquisition and comparison of different mPSCs in the same cells. Further, pharmacological isolation of AMPAergic and GABAergic currents can lead to changes in the amplitude of mPSCs , and this could confound the interpretation of any lidocaineinduced changes.
To examine whether the sPSCs observed in wholecell recordings of E10 chick embryo motoneurons represent mPSCs, we bath applied TTX to block sodiumdependent action potentials. In order to minimize changes in event amplitude that could result from long-duration TTX application , we analyzed events after we established that the drug was effective (see Experimental Procedures).
Shortly after addition of 1 mM TTX, the mean sPSC frequency and amplitude in control motoneurons was not significantly different from that before TTX (0.44 6 0.13 Hz versus 0.43 6 0.06 Hz, p = 0.95, and 11.7 6 0.9 pA versus 11.5 6 0.5 pA, p = 0.88, control versus TTX; n = 7 cells; 1862 events, control; 1903 events, TTX; -70 mV holding potential). A cumulative histogram of sPSC amplitudes shows no difference before or after bath application of TTX ( Figure 1A ; KolmogorovSmirnov [K-S] Z = 0.74; two-tailed p = 0.64). These results suggest that the great majority of the sPSCs recorded in our preparations in between the episodes of SNA (interepisode interval or IEI) are action potential-independent mPSCs. This is consistent with previous findings in unidentified spinal neurons (Chub and O'Donovan, 2001) and demonstrates that very little interneuronal spiking activity exists in the IEI (Ritter et al., 1999; Wenner and O'Donovan, 2001 ). Therefore, TTX was not used further in the study, unless stated, and we refer to these events as mPSCs.
Next, we wanted to determine which neurotransmitters drive these mPSCs. A previous report suggested that unidentified spinal neurons in the E10 chick embryo receive predominantly GABAergic and glutamatergic mPSCs (Chub and O'Donovan, 2001) . To test this for E10 motoneurons, we recorded mPSCs in control and in the presence of bath-applied antagonists. Again, events were analyzed shortly after we established that the drugs were effective (see Experimental Procedures). We observed mPSCs that were sensitive to either the GABA A receptor antagonist bicuculline or the AMPA/ kainate glutamate receptor antagonist CNQX ( Figure 1B) . Bicuculline (20 mM) blocked w75% (2563 mPSCs, n = 7) of the mPSCs, and CNQX (20 mM) blocked w25% (4865 mPSCs, n = 8), such that when both antagonists were added virtually no remaining mPSCs were observed ( Figure 1B , 9 mPSCs, n = 5). This suggests that mPSCs in E10 motoneurons were composed of only two populations: AMPAergic mPSCs (AMPA-mPSCs) with an average amplitude of 9.8 6 0.5 pA and frequency of 0.22 6 0.03 Hz (n = 9) and GABAergic mPSCs (GABAmPSCs) that had an average amplitude of 15.2 6 1.5 pA and frequency of 0.49 6 0.09 Hz (n = 10). Because the mPSCs were recorded in the interepisode interval at a holding potential of -70 mV, we would not expect to observe NMDA-mediated mPSCs that might contribute at more depolarized potentials.
Separation of GABA-mPSCs and AMPA-mPSCs by their decay kinetics would provide an alternative to separating the different classes of mPSCs by transmitter receptor antagonists . Consequently, we assessed the kinetics of mPSCs in chick embryo motoneurons. The time constants for the decay phase of the pharmacologically isolated AMPA-mPSCs occupied the fastest part of the distribution, while the decay time constants for GABA-mPSCs occupied the slowest part of the distribution (Figures 2B and 2D ; average t AMPA = 17.0 6 1.4 ms, average t GABA = 45.5 6 2.2 ms). As we analyzed the decay kinetics of the pharmacologically isolated mPSCs, we observed that w90% of the AMPA-mPSCs (92.1%) and GABA-mPSCs (88.9%) had decay constants below 25 ms and above 30 ms, respectively. In these same cells, we then made an estimation of the contamination in the kinetically isolated populations. Only 8.3% 6 0.4% of the mPSCs with decay constants below 25 ms (presumptive AMPAergic) were GABAergic (based on pharmacologically isolated mPSCs in those cells). Similarly, only 7.6% 6 0.6% of the mPSCs with decay constants above 30 ms (presumptive GABAergic) were AMPAergic. When we isolated mPSCs based on their kinetics, we found that the amplitude and frequency of fast mPSCs were not significantly different from pharmacologically isolated AMPAergic mPSCs ( Figures 3A and 3B ). The amplitude and frequencies of slow mPSCs were similar to the pharmacologically isolated GABAergic mPSCs (Figures 3A and 3B) . These findings suggested that we could isolate predominantly glutamatergic versus GABAergic mPSCs based on their kinetics. Hereafter, we refer to kinetically isolated mPSCs as AMPA-or GABA-mPSCs (AMPA-mPSCs <25 ms; GABA-mPSCs >30 ms; 25-30 ms were not included in further analysis). These findings are consistent with previous reports in which GABAergic/glycinergic mPSCs and glutamatergic mPSCs could be separated based on their slower and faster kinetics, respectively (Galante et al., 2000; Weiner et al., 2005) .
Lidocaine Significantly Reduces Spontaneous Network Activity In Ovo
In order to block SNA in ovo, lidocaine, a sodium channel blocker, was pumped continuously onto the chorioallantoic membrane of E8 embryos for 2 days (from E8 to E10, stages 33 to 36). The effect of lidocaine on spontaneous network activity was observed during this period by monitoring spinally generated embryonic movements. Glass windows in the eggs allowed us to view limb movements in embryos continuously infused with Tyrode's solution by itself or containing lidocaine hydrochloride (35 mg/ml), at a rate of 17.5 ml/hr. In order to quantify the limb movements, we counted the effective time the chick embryo moved during a 3 min period of observation. After 1 day, lidocaine-treated embryos were active for only 2.0 6 0.8 s versus 21.5 6 2.7 s for saline-injected controls. By the end of the second day, lidocaine-treated embryos were active only 0.6 6 0.3 s versus 42.5 6 2.4 s for the control. This progressive reduction in embryonic kicking over the 2 day infusion period was likely the result of a buildup of lidocaine in the egg. The viability of the eggs under treatment was approximately 75%. Several findings suggest that the reduction in embryonic activity is not a function of compromised health, as control and lidocaine-treated embryos were no different in many aspects: development (stage 36 at E10), weight (control embryos were 2.53 6 0.06 g, n = 10; lidocaine-treated embryos weighed 2.61 6 0.08 g, n = 7; p = 0.62), activity patterns of antagonist motoneurons ( Figure 4A ), motoneuron passive membrane properties (Table 1) , and mPSC kinetics (see below). Further, isolated spinal cord preparations from lidocaine-treated embryos expressed robust spontaneous network activity in vitro at a constant frequency throughout the day of the experiment (see below, Figure 4D ).
Lidocaine-Treated Embryos Exhibited an Increased Frequency of Spontaneous Network Activity In Vitro
Following the 2 day infusion of lidocaine or saline, embryos were dissected and spinal cords were isolated with intact muscle nerves. Extracellular muscle nerve recordings were then obtained using suction electrodes, which provide a monitor of the frequency of episodes of SNA. Spinal cords were maintained in recirculating Tyrode's solution in the absence of lidocaine. A significant decrease in the interval between episodes of SNA was found in lidocaine-treated embryos (6.6 6 0.4 min IEI) compared to controls (12.1 6 1.0 min IEI; Figures  4B-4D ), and this difference was maintained throughout the recording period ( Figure 4D ). This reduced IEI suggested that the threshold for the initiation of episodes was attained sooner in the lidocaine-treated embryos, consistent with the idea that these preparations were more excitable. Further, the duration of the episodes was shorter in lidocaine-treated embryos (lidocaine, 1.2 6 0.1 min, versus control, 1.5 6 0.1 min, p < 0.05). It has been demonstrated in the chick embryo that the IEI is correlated to the duration of the following episode (Tabak et al., 2001 ).
Activity-Reduced Embryos Exhibit Increased AMPA-mPSC Amplitude and Frequency Whole-cell recordings were obtained from spinal motoneurons identified antidromically in either lidocainetreated or control embryos ( Figure 4E ). There were no significant differences observed in passive membrane properties between the two groups (Table 1) . mPSCs were recorded in voltage clamp at -70 mV, and AMPAmPSCs were then isolated by their kinetics as described above (no TTX or receptor antagonists were added). The average amplitude of AMPA-mPSCs from motoneurons of lidocaine-treated embryos was larger than in control (control, 8.8 6 0.5 pA; lidocaine-treated embryos, 13.0 6 1.2 pA; p < 0.005; Figures 5A-5C ). No significant change was found in the AMPA-mPSC kinetics as revealed by comparing the rise and decay times of treated and untreated embryos ( Figure 5A ). The increase in AMPA-mPSC amplitude was consistent, in that every motoneuron from the lidocaine-treated embryo had a larger average AMPA-mPSC than any motoneuron from the control. Applying a Kolmogorov-Smirnov test to the cumulative distribution of AMPA-mPSC amplitudes, we found a significant shift to larger amplitudes (B) Cumulative histogram shows distributions of all AMPA-mPSC amplitudes for motoneurons from control and lidocaine-treated embryos (left). Note the rightward shift in lidocaine distribution, showing that these amplitudes were larger. When the control distribution is multiplied by a factor (1.43), we can assess synaptic scaling across the entire distribution (right). Because the curves do not completely overlap, the amplitude distributions cannot be considered to scale. The average amplitude (C) and frequency (D) of AMPA-mPSCs is significantly increased in activity-reduced motoneurons compared to control. Error bars, SE.
for lidocaine-treated motoneurons through most of the AMPA-mPSC distribution (Figure 5B , left; K-S Z = 2.6; two-tailed p < 0.01). The increase, however, was not uniform along the distribution, because multiplying the distribution of amplitudes by a given factor was unable to align the cumulative distributions for control and lidocaine-treated AMPA-mPSCs ( Figure 5B , right). Although this may seem to argue against it, scaling of AMPAergic inputs may still occur (see Discussion). Additionally, the frequency of the AMPA-mPSCs was dramatically increased in activity-reduced preparations (0.17 6 0.04 Hz in control to 0.66 6 0.13 Hz in the lidocaine-treated embryos; p < 0.0001; Figure 5D ). Because we saw an increase in the number of AMPA-mPSCs, we considered the possibility that in motoneurons of lidocaine-treated embryos some of the currents were generated by action potentials. We therefore bath applied 1 mM TTX in some of these preparations, but did not see a significant change in either average amplitude (control, 16.7 6 1.4 pA; then after TTX, 16.4 6 1.1 pA; p = 0.80) or in frequency (control, 1.51 6 0.22 Hz; then after TTX, 1.48 6 0.17 Hz; control, 1986 events; TTX, 1975 events in seven different preparations; p = 0.89) of mPSCs (GABA A and AMPA combined). These results suggested that the increased frequency of events observed in activity-reduced embryos was not due to the appearance of action potential-dependent events.
To test the possibility that the increased number of fast mPSCs (decay constant <25 ms) observed in lidocaine-treated motoneurons was not AMPA mediated, some lidocaine-treated motoneurons were recorded before and after bath application of different receptor antagonists. As expected, addition of CNQX reduced the frequency of fast mPSCs to 4.8% of the pre-drug levels (115 out of 2416 mPSC events; n = 6 different cells). When bicuculline and CNQX were added, the mPSCs were completely abolished. These findings suggest that the increased frequency of fast mPSCs in lidocaine-treated motoneurons was composed of increased numbers of AMPAergic mPSCs and not a new population of mPSCs with a different pharmacology.
Lidocaine Treatment Increased GABA-mPSC Amplitude but Not Frequency In the same set of motoneurons, we isolated the GABAmPSCs by their slower kinetics. Reducing spontaneous network activity for 2 days significantly increased GABA-mPSC amplitude (lidocaine-treated embryos, 19.7 6 2.0 pA; control, 13.4 6 1.1 pA; p < 0.01; Figure 6 ). The kinetics of the GABA-mPSCs were not significantly altered by the treatment ( Figure 6A ). Unlike AMPAmPSCs, the increase in amplitude was uniform along the entire distribution for GABA-mPSCs, as was established by the K-S test (K-S Z = 7.75; p < 0.01) and could (B) Cumulative histogram shows distributions of all GABA-mPSC amplitudes for motoneurons from control and lidocaine-treated embryos (left). Note the rightward shift in lidocaine distribution, showing that these amplitudes were larger. When the control distribution is multiplied by a factor (1.323), we can assess synaptic scaling across the entire distribution (right). Because the curves completely overlap, the amplitude distributions can be considered to scale. The average amplitude (C) but not frequency (D) of GABAmPSCs significantly increased in activityreduced motoneurons compared to control. Error bars, SE.
be multiplicatively scaled over the cumulative distribution of amplitudes ( Figure 6B ). Also distinct from AMPA-mPSCs, GABA-mPSC frequency was not significantly increased in lidocaine-treated embryos (control, 0.45 6 0.08 Hz; lidocaine-treated, 0.55 6 0.10; K-S Z = 1.41; Figure 6D ).
We also pharmacologically isolated GABA-mPSCs in some lidocaine-treated motoneurons, as was done for glutamatergic mPSCs above. Bath application of bicuculline reduced the frequency of slow mPSCs (decay constant >30 ms) to 4.4% (48 slow mPSCs out of 1084; n = 6), and the remaining mPSCs were eliminated by CNQX. These results suggest that the slow mPSCs in both control and lidocaine-treated embryos were GABAergic. Collectively, the results show that a reduction of spontaneous network activity results in no change to the frequency of the GABA-mPSCs, but an upward scaling of amplitude across the entire population of GABA-mPSCs.
Modulation of Synaptic Strength in Interepisode
Interval Is Altered in Activity-Reduced Preparations Previous reports have shown that synaptic strength undergoes a fast, transient modulation (minutes) such that synaptic strength is reduced following an episode of SNA and then recovers in the interval between episodes (Chub and O'Donovan, 2001; Fedirchuk et al., 1999) . This synaptic recovery process is thought to underlie the generation of the next episode (Marchetti et al., 2005; Tabak et al., 2000 Tabak et al., , 2001 . Therefore, it was possible that the increase in mPSC amplitude observed in the lidocaine-treated motoneurons occurred because episodes of SNA did not depress synaptic currents as significantly as in the control. In order to test this possibility, we analyzed mPSC amplitude in 2 min bins before and after an episode. Because we did not observe a strong modulation of AMPA-mPSC amplitude, this possibility can't explain the lidocaine-induced increase in AMPA-mPSC amplitude (Table 2, Figure 7A ). We did observe a clear depression of GABA-mPSC amplitude after an episode of SNA ( Figure 7B , Table 2 ). However, the amplitude depression, as a percentage of the preepisode value, was no different in lidocaine-treated and control embryos. This suggested that the SNAinduced depression could not explain the increase in GABA-mPSC amplitude observed in activity-reduced preparations.
GABA-mPSC amplitude then recovered in the interepisode interval such that the value 2 min before the next episode was not significantly different from the value 2 min before the previous episode (n = 7 for control or n = 8 for lidocaine-treated embryos, data not shown). Because mPSCs fully recover before the next episode and because the interval is half as long in lidocaine preparations, we might expect that the recovery process is faster in lidocaine-treated embryos. This is precisely what we observed. GABA-mPSC amplitude averaged in the 2 min just after an episode was reduced to about 70% (control) or 63% (lidocaine) of that just before the episode ( Figure 7B ). The amplitude then progressively recovered in sequential 2 min periods after the episode. Although the control and lidocaine GABA-mPSC amplitudes were similarly depressed, their recovery in lidocaine preparations had been accelerated, as demonstrated by the increased slope for lidocaine preparations ( Figure 7B ). The findings suggest that the interepisode synaptic modulation of GABA-mPSC amplitude is itself modulated in the activity-reduced embryos.
Synaptic Strength Correlates with SNA Frequency
If the lidocaine-induced increases in GABA A and AMPA synaptic strength are at least partly responsible for the more frequent episodes of spontaneous network activity, then we would expect that reducing synaptic strength in these preparations would reduce SNA frequency. This was tested in lidocaine-treated embryos by bath applying subsaturating concentrations of GABA A and AMPA receptor antagonists while recording episodes from the isolated spinal cord preparations. We found that the 5 mM bicuculline reduced GABA Amediated ventral root-evoked ventral root responses to 46.1% 6 6.1% of pre-drug responses (nine ventral roots, five preparations), and therefore, it is likely that GABA-mPSCs are similarly reduced in amplitude. In these lidocaine preparations, the IEI increased from 463 6 20 s to 826 6 76 s following bath application of 5 mM bicuculline ( Figure 7C , p < 0.001). Further, upon addition of 4 mM CNQX, which reduced the glutamatergic dorsal root-evoked ventral root response to 40.3% 6 4.6% of the control response (five ventral roots, four preparations), the interval was further increased to 1022 6 128 s (p < 0.001, not significantly different from bicuculline alone, Friedman test, Dunn post hoc). These findings are important because they demonstrate a link between synaptic strength and SNA frequency and suggest that the observed increase in synaptic strength of lidocaine preparations would be expected to produce shorter intervals. Discussion SNA has been described in most developing networks, but its function in the maturation of these circuits is Table 2 . Modulation of mPSC Amplitude by SNA Network Activity Regulates Embryonic Synapsespoorly understood. In this report, we demonstrate that reducing spontaneous network activity in the living embryo leads to increases in the synaptic strength of excitatory GABAergic and glutamatergic inputs to motoneurons. Because SNA regulates synaptic strength during a period of development when significant changes take place, it will likely play a critical role in the coordinated maturation of the strength of excitatory and what will become inhibitory synapses. Further, we demonstrate changes in multiple aspects of synaptic strength, including mPSC amplitude, frequency, and modulation, which could underlie the increased excitability of the activity-reduced cords. All of these synaptic changes act in a compensatory manner, suggesting that SNA could homeostatically regulate itself. Similar compensatory synaptic responses, often referred to as synaptic homeostasis, have been described in culture, the visual system, and the NMJ. Here we demonstrate this phenomenon in a new functional context, regulating SNA in the intact motor system. , 1998) . Many other studies have observed similar compensatory changes in synaptic strength, and these changes can occur through different synaptic mechanisms (Burrone and Murthy, 2003; Burrone et al., 2002; Davis and Bezprozvanny, 2001; Desai et al., 2002; Kilman et al., 2002; O'Brien et al., 1998; Paradis et al., 2001; Perez-Otano and Ehlers, 2005; Thiagarajan et al., 2002; Turrigiano et al., 1998; Turrigiano and Nelson, 2004; Wang et al., 2005) . One particular class of compensatory synaptic change in mPSC amplitude has been referred to as synaptic scaling, where all of a cell's GABAergic or AMPAergic mPSCs are increased or decreased by a multiplicative factor following changes in network activity (Desai et al., 2002; Kilman et al., 2002; Turrigiano et al., 1998; Turrigiano and Nelson, 2004) . In this report, we test whether similar mechanisms could exist in the embryo to maintain spontaneous network activity.
We have reduced SNA in the living embryo for 2 days, and we show compensatory changes in AMPA and GABA A synaptic strength that could act to homeostatically maintain SNA levels in the developing spinal cord. We have carried out these experiments in a favored developmental system, the chick embryo, because the system offers several advantages. It was possible to reduce activity levels in the embryo by infusing lidocaine into the egg. Also, we could record from a relatively homogeneous population of spinal motoneurons. This was only possible because we did not need to add TTX to isolate mPSCs and could therefore identify the motoneurons by the antidromic activation of their axons. Further, these motoneurons only exhibited GABA A and AMPA receptor-mediated mPSCs, which could be separated by their decay kinetics. This was a significant advantage because long-term application of a neurotransmitter receptor antagonist can alter the amplitude of the unblocked mPSCs .
Changes to mPSC Amplitude Following a Reduction in Spontaneous Network Activity
We have observed a compensatory synaptic regulation in embryonic development. As with previous studies in culture and in vivo, reductions in network activity produced an increase in AMPA mPSC amplitude that would likely compensate for the lowered network activity levels. Unlike previous studies, we did not observe multiplicative scaling of the AMPA mPSC amplitudes. However, because we observed a striking >3-fold increase in the number of AMPA-mPSCs (see below), it is impossible to confirm or deny the possibility that a scaling process occurred. AMPA-mPSCs might have scaled, but our ability to observe scaling could have been obscured by lidocaine-induced mPSCs with a different amplitude distribution. For instance, new connections could have formed that were of smaller amplitude. Alternatively, AMPAergic inputs from different classes of neuron may be regulated differently, as has been described for GABAergic inputs in the developing visual cortex (Maffei et al., 2004) .
In culture experiments, following activity blockade GABA A mIPSC amplitudes were multiplicatively scaled downward (Kilman et al., 2002; Swanwick et al., 2005) . Additionally, some evidence suggests that synaptic projections from certain inhibitory neurons in the visual cortex can weaken following monocular deprivation in the neonatal rat (Maffei et al., 2004) . In these previous studies, reducing network activity resulted in compensatory synaptic changes by reducing inhibitory synaptic strength. One might expect GABA-mPSCs to be regulated in the same way in the embryo. Alternatively, if the function of the synaptic modifications is to compensate for lowered activity levels, then we might expect reductions in network activity to lead to an increase in GABAergic synaptic strength since GABA is depolarizing and can be excitatory in the embryo (Ben-Ari, 2002) . Indeed, GABA-mPSC amplitude did increase in lidocaine preparations, suggesting a distinct form of synaptic compensation in the embryo. Moreover, synaptic scaling across the entire distribution of GABAergic mPSCs was observed. This suggests that all GABAergic inputs to spinal motoneurons were increased by the same factor. This provides an in vivo demonstration of synaptic scaling of mPSCs mediated by an inhibitory neurotransmitter.
Increases in the strength of excitatory synaptic connections are thought to help restore activity to control levels following a period of reduced activity; however, this assumption has rarely been tested (Maffei et al., 2004) . We have shown that following a reduction of SNA, AMPA and GABA A synaptic strength increases, and this increase is associated with more frequent episodes of SNA. Previous studies using the embryonic spinal cord preparation have shown that blockade of different transmitter receptors, including nicotinic, GABA A , glycine, AMPA, and NMDA receptors, results in a slowing of the network activity, suggesting that excitatory synaptic strength can influence the frequency of SNA Hanson and Landmesser, 2003; Milner and Landmesser, 1999; Wenner and O'Donovan, 2001 ). In lidocaine-treated preparations, the increased strength of GABAergic and AMPAergic synapses was reduced toward control values by subsaturating concentrations of receptor antagonists, and this did reduce the frequency of SNA close to control values. While these findings do not establish causality, they do predict that the increased excitatory synaptic strength of activity-reduced preparations would be likely to contribute to the observed increase in SNA frequency.
Evidence for changes in mPSC amplitude supports both postsynaptic changes in receptor number (Kilman et al., 2002; Lissin et al., 1998; O'Brien et al., 1998; Swanwick et al., 2005; Thiagarajan et al., 2005; Turrigiano et al., 1998; Wierenga et al., 2005) and presynaptic changes in vesicle loading De Gois et al., 2005; Frerking et al., 1995; Karunanithi et al., 2002; Swanwick et al., 2005; Wilson et al., 2005) . These pre-and/or postsynaptic mechanisms could account for the increases in mPSC amplitude observed in the activity-reduced preparations in this study. However, they are unlikely to explain the observed changes in the interepisode modulation of GABAmPSC amplitude. In control preparations, GABA A currents are depressed following an episode of SNA and progressively recover during the following interepisode interval (Chub and O'Donovan, 2001; Fedirchuk et al., 1999) . In the lidocaine-treated preparations, GABAmPSC amplitude was similarly depressed by the episode, but recovered in the IEI faster than controls. Therefore, interepisode modulation had itself been modulated by reducing SNA. The interepisode modulation of GABA A currents in the control chick spinal cord occurs through a redistribution of chloride ions (Chub and O'Donovan, 2001) . During the interval, the concentration of intracellular chloride increases, thereby increasing the driving force for GABA A currents. Because the rate of chloride redistribution is likely determined by chloride pumps, we are now focusing on the possibility that an increase in function of chloride pumping could underlie the increased rate of recovery of GABA-mPSC amplitude in lidocaine preparations. These changes in the interepisode modulation of mPSC amplitude introduce a compensatory synaptic response dependent on the transient developmental phenomenon of SNA. Although there was a minor modulation of the amplitude of AMPA-mPSCs, it was small and could result from the small fraction of GABA-mPSCs that contaminate the kinetically isolated AMPA-mPSC population.
Assuming that the GABAergic scaling process in the embryo is similar to that described in culture, then it is likely that the GABA A receptor itself is part of the mechanism that determines whether to scale mPSC amplitudes up or down following activity block. This is suggested by the observation that the scaling polarity is in opposite directions when the chloride current is excitatory (embryo) versus inhibitory (culture). This may suggest that the mechanism that determines scaling polarity is controlled by the excitatory or inhibitory nature of current flow through GABA A receptors, although we cannot rule out the possibility that it is determined by the subunit composition of embryonic and mature forms of the receptor (Fritschy et al., 1994; Laurie et al., 1992) .
Changes to mPSC Frequency Following a Reduction in Spontaneous Network Activity
In the chick embryo, following 2 days of reduced spontaneous network activity, motoneurons exhibited increased AMPA-mPSC frequency, while that of GABAmPSCs was unchanged. Increases in AMPA-mPSC frequency could act to homeostatically recover higher levels of network activity. Previous reports have demonstrated that perturbing activity levels can result in changes in AMPA-mPSC frequency (Burrone et al., 2002; Galante et al., 2000; Lissin et al., 1998; Thiagarajan et al., 2002 ). An increase in AMPA-mPSC frequency is generally considered to occur as a presynaptic event, although we cannot rule out the possibility that there was an unmasking of silent synapses (Isaac, 2003; Nicoll, 2003) . The probability of spontaneous release may be higher in lidocaine-treated embryos, or more AMPAergic synapses could have developed. It is possible that synapses were added in an input-specific manner following the reduction of activity (Maffei et al., 2004) , which could alter the amplitude distribution histograms as noted above. Reductions in spontaneous network activity may have produced changes in AMPA-but not GABAmPSC frequency because GABAergic and AMPAergic synapses were at different maturational states. It is known that GABAergic synapses precede the development of glutamatergic synapses in many systems (BenAri and , including the chick embryo spinal cord (Milner and Landmesser, 1999) .
Spontaneous Network Activity and Synaptic Maturation
Before synaptic connections form, calcium spike activity appears to regulate neurotransmitter phenotype in a compensatory manner (Borodinsky et al., 2004) . Following the formation of synaptically connected networks, SNA is observed for a transient period in most developing circuits (Ben-Ari, 2001; Feller, 1999; Fortin et al., 1995; Gummer and Mark, 1994; Ho and Waite, 1999; Itaya et al., 1995; Lippe, 1995; O'Donovan, 1999; Wong, 1999) . In the spinal cord, SNA is important for generating embryonic movements critical to the proper development of motor axons, muscles, and joints (Hall and Herring, 1990; Hanson and Landmesser, 2004; Jarvis et al., 1996; Persson, 1983; Roufa and Martonosi, 1981; Ruano-Gil et al., 1978; Toutant et al., 1979) . Despite the importance of SNA, its function in network maturation is unknown.
Amphibians raised in the absence of network activity had no clear abnormalities in spinal circuitries generating swimming behaviors (Harrison, 1904; Haverkamp and Oppenheim, 1986; Oppenheim and Haverkamp, 1986) . These experiments have been interpreted to suggest that the circuitry is relatively normal. In a separate set of experiments in the chick embryo, where spinal activity may have been perturbed by in ovo curare application, the pattern of connectivity between muscle sensory neurons and motoneurons was normal; however, the amplitude of evoked potentials was larger (Mendelson and Frank, 1991 ). Our results demonstrate that spontaneous network activity can regulate the synaptic strength of motoneuron inputs. By reducing this activity in ovo for 2 days, we saw compensatory increases in both glutamatergic and depolarizing GABAergic mPSCs. Therefore, SNA appears to regulate the strength of network connections in a manner that could maintain levels of activity appropriate for proper limb development. Future studies increasing SNA will be necessary to more completely determine the homeostatic nature of this synaptic regulation. By regulating synaptic strength in the embryo, spontaneous network activity is likely to be important for the maturation of synaptic strength. SNA is particularly well suited to drive the maturation of synaptic inputs, because the great majority of spinal neurons, and their synapses, are recruited during episodes. Interestingly, the spiking activity levels in spinal interneurons appear to be lower than that of motoneurons during SNA episodes and the interepisode interval (Chub and O'Donovan, 2001; Ritter et al., 1999; Wenner and O'Donovan, 2001) . If synaptic strength is regulated in a similar way for interneurons, then we might expect compensatory responses to be triggered at different activity levels for different neurons.
Based on the level of SNA, the synaptic strength of excitatory and what will become inhibitory inputs could be coordinately adjusted to maintain the activity as challenges to the efficacy of both types of synapses are presented (e.g., changes in cell size). Because of their shared depolarizing nature, certain features of excitatory and inhibitory synapses could be regulated in a mechanistically similar way, producing an initial coordinated development of the two systems. Therefore, this may provide a balanced development of the synaptic strength of excitatory and inhibitory connections during a dynamic period of embryonic development. Because spontaneous network activity appears to occur in virtually every developing circuit, it is possible that this activity is important for synaptic maturation throughout the nervous system.
Experimental Procedures Dissection
White Leghorn chicken eggs (Hy-Line Chicks, Mansfield, GA) were dissected as described previously (Wenner and O'Donovan, 2001) . Briefly, spinal cords were isolated at E10 (stage 36). The lumbosacral spinal cord region with attached femorotibialis (external and medial heads) and adductor muscle nerves was dissected under cooled (15ºC) oxygenated Tyrode's solution containing (in mM): 139 NaCl, 12 D-glucose, 17 NaHCO 3 , 3 KCl, 1 MgCl 2 , and 3 CaCl 2 . After dissection, the cords were allowed to recover for at least 6 hr in oxygenated Tyrode's at 17ºC. After recovery, the cords were transferred to a recording chamber, continuously perfused with oxygenated Tyrode's solution with 5 mM KCl, and recordings were performed at 28ºC. The dissection, recovery, and recording periods took place in the absence of lidocaine.
Electrophysiology
Whole-cell voltage-clamp recordings were obtained and mPSCs were recorded from motoneurons antidromically identified as femorotibialis or adductor motoneurons by the stimulation of their muscle nerves through tight-fitting suction electrodes (50 mA, 50 ms stimulus with an ISO-Flex stimulus isolator, A.M.P.I.). Muscle nerve recordings were obtained from these suction electrodes connected to high-gain differential amplifiers (A-M systems). In 15 femorotibialis and 14 adductor motoneurons (19 embryos), there were no significant differences in membrane potential (fem versus add, 254.3 6 2.4 mV versus 251.4 6 1.7 mV), input resistance (642 6 28 MU versus 644 6 25 MU), or capacitance (27.1 6 1.5 pF versus 27.3 6 1.2 pF). Also, the mPSC mean amplitude and frequency were no different in femorotibialis or adductor motoneurons (amplitude: 12.7 6 0.8 pA versus 12.1 6 1.0 pA, p = 0.15; frequency: 0.49 6 0.10 Hz versus 0.42 6 0.12 Hz, p = 0.68), and therefore the data were combined for the study. Tight seals (>2 GU) were obtained. Patch electrodes (6-10 MU) had series resistance from 10 to 20 MU and was not compensated. Recordings were terminated whenever significant increases in input resistance (>20%) occurred. The intracellular patch solution contained (in mM): 10 NaCl, 94 K-gluconate, 36 KCl, 10 HEPES, 1.1 EGTA, 1 MgCl 2 , 0.1 CaCl 2 , 1 Na 2 ATP, and 0.1 MgGTP and pH was 7.3. Whole-cell currents were acquired using an AxoClamp 2B amplifier, controlled by Axograph 4.9 software (Axon Instruments,) or an EPC8 amplifier using Patchmaster software (HEKA). Currents were filtered online at 5 kHz, digitized at 10 kHz. Only cells showing a stable resting membrane potential (more negative than 45 mV for 1-2 hr) were used for analysis.
Lidocaine Infusion
At E8 (Hamburger and Hamilton, 1951) , a lateral window was opened to allow monitoring of chick embryo movements and drug application. Lidocaine hydrochloride (Sigma-Aldrich) aqueous solution (35 mg/ml plus 10 mM HEPES, pH 7.2) was continuously applied onto the chorioallantoic membrane of the chick embryos at a rate of 13.5 ml/hr with an infusion pump. Suppression of activity was monitored by counting chick embryo kicking activity during 3 min at different times during treatment. Only eggs with a cardiac rate above 80 beats per minute at E10 were used (the normal mean heart rate of untreated E10 embryos was 165 6 2.3, n = 10, while that for treated E10 embryos was 114 6 5, n = 10, at the end of the perfusion period).
mPSC Analysis
We tested our space clamp by comparing rise times, half-widths, and amplitude. If there was a poor space clamp, our mPSCs would be filtered and appear to have longer rise times, smaller amplitudes, and longer decays (Rall, 1969) . We found no significant correlation in the relationship between the mPSC half-width and rise time (r = 0.4) or between the decay time and amplitude (Figure 2A ; r = 0.67) or between decay time and amplitude in GABA-mPSC or AMPA-mPSC (r = 0.22 and 0.03, respectively). These findings suggest that cells were space clamped reasonably well. mPSCs were analyzed using Minianalysis software (Synaptosoft, Inc.). mPSCs were acquired in the IEI starting immediately after the episode and continuing until the average IEI for that kind of preparation (control, 12 min; lidocaine preparation, 6 min). If episode intervals were shorter than the average interval, the complete interval was acquired. For acquisition of mPSCs in the presence of TTX, we added the sodium channel blocker immediately following an episode and waited 5 min past the time that the next episode would be expected to occur, based on the average interval for that preparation. Then mPSCs were acquired for 6 (lidocaine preparations) or 12 min (control preparations). This allowed us to acquire longer periods in control motoneurons, thereby increasing our sample of the less frequent AMPA-mPSCs. In order to observe pharmacologically isolated mPSCs, neurotransmitter receptor antagonists were added shortly after an episode and recordings were then acquired in the interval after the next episode (this was typically >30 min after drug application). Generally, drugs begin to be effective within 5-10 min. We only recorded one cell per preparation for experiments using drugs.
Statistics
Data from averages are expressed as mean 6 SEM. Most statistical analysis was performed using a two-tailed Student's t test (paired and unpaired), unless mentioned otherwise. p < 0.05 was considered significant. For cumulative distributions, statistical differences were established using a Kolmogorov-Smirnov two-sample test (a confidence level of 0.05) integrated in the Minianalysis software (Synaptosoft Inc.) and were expressed with the Kolmogorov-Smirnov index, Z (K-S Z), and the probability (p) that the two samples have the same cumulative distribution.
